Company Plans to File Supplemental New Drug Application with FDA in First Quarter 2008
SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today...
- Significant Efforts to Expand Market and Prepare for Zingo Launch Underway -
- Nancy Donahue Promoted To Senior Vice President, Marketing and Sales, and James Carr Promoted To Vice...
Sagent to Accelerate Anesiva's Penetration of the Hospital Market with Zingo
SOUTH SAN FRANCISCO, Calif. and SCHAUMBURG, Ill., Oct. 11 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq:...
New Phase 3 Plan Could Expedite Clinical Development Pathway
SOUTH SAN FRANCISCO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that it will...
SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that John P. McLaughlin, the company's chief executive officer, will present at...
Adlea May Provide Pain Relief Without Opiate-Like Side Effects For Weeks to Months Following a Single Administration
SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire-FirstCall/ --...